These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 30451293)
1. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families. Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293 [TBL] [Abstract][Full Text] [Related]
2. Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain. Sargen MR; Calista D; Elder DE; Massi D; Chu EY; Potrony M; Pfeiffer RM; Carrera C; Aguilera P; Alos L; Puig S; Elenitsas R; Yang XR; Tucker MA; Landi MT; Goldstein AM J Am Acad Dermatol; 2020 Sep; 83(3):860-869. PubMed ID: 32283231 [TBL] [Abstract][Full Text] [Related]
3. Germline TERT promoter mutations are rare in familial melanoma. Harland M; Petljak M; Robles-Espinoza CD; Ding Z; Gruis NA; van Doorn R; Pooley KA; Dunning AM; Aoude LG; Wadt KA; Gerdes AM; Brown KM; Hayward NK; Newton-Bishop JA; Adams DJ; Bishop DT Fam Cancer; 2016 Jan; 15(1):139-44. PubMed ID: 26433962 [TBL] [Abstract][Full Text] [Related]
4. Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma. Wong K; Robles-Espinoza CD; Rodriguez D; Rudat SS; Puig S; Potrony M; Wong CC; Hewinson J; Aguilera P; Puig-Butille JA; Bressac-de Paillerets B; Zattara H; van der Weyden L; Fletcher CDM; Brenn T; Arends MJ; Quesada V; Newton-Bishop JA; Lopez-Otin C; Bishop DT; Harms PW; Johnson TM; Durham AB; Lombard DB; Adams DJ JAMA Dermatol; 2019 May; 155(5):604-609. PubMed ID: 30586141 [TBL] [Abstract][Full Text] [Related]
11. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Shi J; Yang XR; Ballew B; Rotunno M; Calista D; Fargnoli MC; Ghiorzo P; Bressac-de Paillerets B; Nagore E; Avril MF; Caporaso NE; McMaster ML; Cullen M; Wang Z; Zhang X; ; ; ; Bruno W; Pastorino L; Queirolo P; Banuls-Roca J; Garcia-Casado Z; Vaysse A; Mohamdi H; Riazalhosseini Y; Foglio M; Jouenne F; Hua X; Hyland PL; Yin J; Vallabhaneni H; Chai W; Minghetti P; Pellegrini C; Ravichandran S; Eggermont A; Lathrop M; Peris K; Scarra GB; Landi G; Savage SA; Sampson JN; He J; Yeager M; Goldin LR; Demenais F; Chanock SJ; Tucker MA; Goldstein AM; Liu Y; Landi MT Nat Genet; 2014 May; 46(5):482-6. PubMed ID: 24686846 [TBL] [Abstract][Full Text] [Related]
12. Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families. Potjer TP; Bollen S; Grimbergen AJEM; van Doorn R; Gruis NA; van Asperen CJ; Hes FJ; van der Stoep N; Int J Cancer; 2019 May; 144(10):2453-2464. PubMed ID: 30414346 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families. Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811 [TBL] [Abstract][Full Text] [Related]
14. Characterization of melanoma susceptibility genes in high-risk patients from Central Italy. Pellegrini C; Maturo MG; Martorelli C; Suppa M; Antonini A; Kostaki D; Verna L; Landi MT; Peris K; Fargnoli MC Melanoma Res; 2017 Jun; 27(3):258-267. PubMed ID: 28146043 [TBL] [Abstract][Full Text] [Related]
15. [Increased knowledge on familial melanoma and the underlying genetics]. Helgadottir H; Nielsen K; Höiom V Lakartidningen; 2017 May; 114():. PubMed ID: 28485764 [TBL] [Abstract][Full Text] [Related]
16. Mutation screening of the CDKN2A promoter in melanoma families. Harland M; Holland EA; Ghiorzo P; Mantelli M; Bianchi-Scarrà G; Goldstein AM; Tucker MA; Ponder BA; Mann GJ; Bishop DT; Newton Bishop J Genes Chromosomes Cancer; 2000 May; 28(1):45-57. PubMed ID: 10738302 [TBL] [Abstract][Full Text] [Related]
17. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study. Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G; BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929 [TBL] [Abstract][Full Text] [Related]
18. Constitutional variants in POT1, TERF2IP, and ACD genes in patients with melanoma in the Polish population. Malińska K; Deptuła J; Rogoża-Janiszewska E; Górski B; Scott R; Rudnicka H; Kashyap A; Domagała P; Hybiak J; Masojć B; Cybulski C; Kram A; Boer M; Kiedrowicz M; Lubiński J; Dębniak T Eur J Cancer Prev; 2020 Nov; 29(6):511-519. PubMed ID: 32976206 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations. Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189 [TBL] [Abstract][Full Text] [Related]
20. High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families. Mantelli M; Barile M; Ciotti P; Ghiorzo P; Lantieri F; Pastorino L; Catricalà C; Torre GD; Folco U; Grammatico P; Padovani L; Pasini B; Rovini D; Queirolo P; Rainero ML; Santi PL; Sertoli RM; Goldstein AM; Bianchi-Scarrà G; ; Am J Med Genet; 2002 Jan; 107(3):214-21. PubMed ID: 11807902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]